This article is more than 5 years old. Information may no longer be current.

Alimera Sciences introduces emollient dry-eye drop

Add topic to email alerts

Receive an email when new articles are posted on

Please provide your email address to receive an email when new articles are posted on .

Subscribe

Added to email alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

Back to Healio

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Back to Healio

ATLANTA — A new dry eye drop is the first multidose, emollient-based artificial tear product to be introduced to the market, according to the drop’s marketer.

Alimera Sciences’ Soothe Emollient Eye Drops use an “advanced lipid restorative” to re-establish the eye’s protective lipid layer to reduce tear evaporation and seal essential moisture, according to a company press release. Alimera said it expects to have the product available in U.S. retail outlets beginning next month.

Alimera licensed the product from Ocular Research of Boston. Alimera Sciences was founded by former Novartis Ophthalmics executives earlier this year and completed a round of venture capital funding last month.